Rheonix

Rheonix, Inc. is committed to raising the standard of care by making molecular diagnostics more accessible to more people, in more places, and more frequently. As scientific knowledge advances, new diagnostic technologies are needed to streamline processes and enhance innovation. With experienced leadership and creative vision, Rheonix has developed the inclusion platform, a highly customizable technology offering unparalleled versatility and affordability. This platform performs fully automated, complex molecular assays on the Rheonix CARD® cartridge, in an easy-to-use and cost-effective format.